Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns // Ärzte und Wissenschaftler schreiben an die Europäische Arzneimittelbehörde und warnen vor den Gefahren des Covid-19-Impfstoffs

 

Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns

Ärzte und Wissenschaftler schreiben an die Europäische Arzneimittelbehörde und warnen vor den Gefahren des Covid-19-Impfstoffs

 

Doctors and scientists can sign the open letter by emailing their name, qualifications, areas of expertise, country and any affiliations they would like to cite, to Doctors4CovidEthics@protonmail.com

֎֎֎

updated: April 4, 2021

 

 

https://doctors4covidethics.medium.com/press-release-urgent-open-letter-to-ema-from-doctors-scientists-regarding-vaccine-safety-a903853bd4c7

Press Release: Urgent open letter to EMA from doctors & scientists regarding vaccine safety concerns

PRESS RELEASE — FOR IMMEDIATE RELEASE

BREAKING NEWS: Doctors and Scientists Write to European Medicines Agency Warning of COVID-19 Vaccine Dangers

10th March 2021

A group of scientists and doctors has today issued an open letter calling on the European Medicines Agency (EMA) to answer urgent safety questions regarding COVID-19 vaccines, or withdraw the vaccines’ authorisation.

The letter describes serious potential consequences of COVID-19 vaccine technology, warning of possible autoimmune reactions, blood clotting abnormalities, stroke and internal bleeding, “including in the brain, spinal cord and heart”. The authors request evidence that each medical danger outlined “was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.”

“Should all such evidence not be available”, the authors write, “we demand that approval for use of the gene-based vaccines be withdrawn until all the above issues have been properly addressed by the exercise of due diligence by the EMA.”

The letter is addressed to Emer Cooke, Executive Director of the EMA, and was sent on Monday 1 March 2021. The letter was copied to the President of the Council of Europe and the President of the European Commission.

It states: “We are supportive in principle of the use of new medical interventions.” However, “there are serious concerns, including but not confined to those outlined above, that the approval of the COVID-19 vaccines by the EMA was premature and reckless, and that the administration of the vaccines constituted and still does constitute ‘human experimentation’, which was and still is in violation of the Nuremberg Code.”

Link to letter: https://doctors4covidethics.medium.com/urgent-open-letter-from-doctors-and-scientists-to-the-european-medicines-agency-regarding-covid-19-f6e17c311595

Video statement by Professor Sucharit Bhakdi, Professor Emeritus of Medical Microbiology and Immunology and Former Chair, Institute of Medical Microbiology and Hygiene: https://lbry.tv/@Doctors4CovidEthics:d/Prof.-Sucharit-Bhakdi-statement-on-EMA-open-letter.ENG:0

For comment contact Professor Sucharit Bhakdi MD: sucharit.bhakdi@gmx.de, or Associate Professor Michael Palmer MD:mpalmer@uwaterloo.ca

In a public statement the group said…

“No sooner did we deliver our letter than the Norwegian Medicines Agency warned that COVID-19 vaccines may be too risky for use in the frail elderly, the very group these vaccines are designed to protect. We would add that, by virtue of the mechanisms of action of the vaccines, to stimulate the production of spike protein, which has adverse pathophysiological properties, there may also be vulnerable people who are not old and already ill. New data shows that vaccine side effects are three times as common in those who have previously been infected with coronavirus, for example. None of the vaccines have undergone clinical testing for more than a few months, which is simply too short for establishing safety and efficacy.

“Therefore, as a starting point, we believe it is important to enumerate and evaluate all deaths which have occurred within 28 days of vaccination, and to compare the clinical pictures with those who have not been vaccinated.

“More broadly, with respect to the development of COVID-19 vaccines, the Parliamentary Assembly of the Council of Europe has stated in their Resolution 2361, on 27th January 2021, that member states must ensure all COVID-19 vaccines are supported by high quality trials that are sound and conducted in an ethical manner. EMA officials, and other regulatory bodies in EU countries, are bound by these criteria. They should be made aware that they may be violating Resolution 2361 by applying medical products still in phase 3 studies.

“Under Resolution 2361, member states must also inform citizens that vaccination is NOT mandatory and ensure that no one is politically, socially, or otherwise pressured to become vaccinated. States are further required to ensure that no one is discriminated against for not receiving the vaccine.”

The letter comes as a petition against UK Government plans for vaccine passports passed 270,000 signatures, more than double that required to compel consideration for debate by MPs. The petition will be debated in the UK Parliament on 15th March 2021.

Doctors and scientists can sign the open letter by sending their name, qualifications, areas of expertise and country of practice to: Doctors4CovidEthics@protonmail.com.

 

֎֎֎

https://doctors4covidethics.medium.com/urgent-open-letter-from-doctors-and-scientists-to-the-european-medicines-agency-regarding-covid-19-f6e17c311595

 

Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns

Doctors for Covid Ethics

 

Emer Cooke, Executive Director, European Medicines Agency, Amsterdam, The Netherlands

28 February 2021

 

Dear Sirs/Mesdames,

FOR THE URGENT PERSONAL ATTENTION OF: EMER COOKE, EXECUTIVE DIRECTOR OF THE EUROPEAN MEDICINES AGENCY

As physicians and scientists, we are supportive in principle of the use of new medical interventions which are appropriately developed and deployed, having obtained informed consent from the patient. This stance encompasses vaccines in the same way as therapeutics.

We note that a wide range of side effects is being reported following vaccination of previously healthy younger individuals with the gene-based COVID-19 vaccines. Moreover, there have been numerous media reports from around the world of care homes being struck by COVID-19 within days of vaccination of residents. While we recognise that these occurrences might, every one of them, have been unfortunate coincidences, we are concerned that there has been and there continues to be inadequate scrutiny of the possible causes of illness or death under these circumstances, and especially so in the absence of post-mortems examinations.

In particular, we question whether cardinal issues regarding the safety of the vaccines were adequately addressed prior to their approval by the European Medicines Agency (EMA).

As a matter of great urgency, we herewith request that the EMA provide us with responses to the following issues:

  1. Following intramuscular injection, it must be expected that the gene-based vaccines will reach the bloodstream and disseminate throughout the body [1]. We request evidence that this possibility was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
  2. If such evidence is not available, it must be expected that the vaccines will remain entrapped in the circulation and be taken up by endothelial cells. There is reason to assume that this will happen particularly at sites of slow blood flow, i.e. in small vessels and capillaries [2]. We request evidence that this probability was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
  3. If such evidence is not available, it must be expected that during expression of the vaccines’ nucleic acids, peptides derived from the spike protein will be presented via the MHC I — pathway at the luminal surface of the cells. Many healthy individuals have CD8-lymphocytes that recognize such peptides, which may be due to prior COVID infection, but also to cross-reactions with other types of Coronavirus [3; 4] [5]. We must assume that these lymphocytes will mount an attack on the respective cells. We request evidence that this probability was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
  4. If such evidence is not available, it must be expected that endothelial damage with subsequent triggering of blood coagulation via platelet activation will ensue at countless sites throughout the body. We request evidence that this probability was excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
  5. If such evidence is not available, it must be expected that this will lead to a drop in platelet counts, appearance of D-dimers in the blood, and to myriad ischaemic lesions throughout the body including in the brain, spinal cord and heart. Bleeding disorders might occur in the wake of this novel type of DIC-syndrome including, amongst other possibilities, profuse bleedings and haemorrhagic stroke. We request evidence that all these possibilities were excluded in pre-clinical animal models with all three vaccines prior to their approval for use in humans by the EMA.
  6. The SARS-CoV-2 spike protein binds to the ACE2 receptor on platelets, which results in their activation [6]. Thrombocytopenia has been reported in severe cases of SARS-CoV-2 infection [7]. Thrombocytopenia has also been reported in vaccinated individuals [8]. We request evidence that the potential danger of platelet activation that would also lead to disseminated intravascular coagulation (DIC) was excluded with all three vaccines prior to their approval for use in humans by the EMA.
  7. The sweeping across the globe of SARS-CoV-2 created a pandemic of illness associated with many deaths. However, by the time of consideration for approval of the vaccines, the health systems of most countries were no longer under imminent threat of being overwhelmed because a growing proportion of the world had already been infected and the worst of the pandemic had already abated. Consequently, we demand conclusive evidence that an actual emergency existed at the time of the EMA granting Conditional Marketing Authorisation to the manufacturers of all three vaccines, to justify their approval for use in humans by the EMA, purportedly because of such an emergency.

Should all such evidence not be available, we demand that approval for use of the gene-based vaccines be withdrawn until all the above issues have been properly addressed by the exercise of due diligence by the EMA.

There are serious concerns, including but not confined to those outlined above, that the approval of the COVID-19 vaccines by the EMA was premature and reckless, and that the administration of the vaccines constituted and still does constitute “human experimentation”, which was and still is in violation of the Nuremberg Code.

In view of the urgency of the situation, we request that you reply to this email within seven days and address all our concerns substantively. Should you choose not to comply with this reasonable request, we will make this letter public.

This email is copied to:

Charles Michel, President of the Council of Europe

Ursula von der Leyen, President of the European Commission.

Doctors and scientists can sign the open letter by emailing their name, qualifications, areas of expertise, country and any affiliations they would like to cite, to Doctors4CovidEthics@protonmail.com

  • References

[1] Hassett, K. J.; Benenato, K. E.; Jacquinet, E.; Lee, A.; Woods, A.; Yuzhakov, O.; Himansu, S.; Deterling, J.; Geilich, B. M.; Ketova, T.; Mihai, C.; Lynn, A.; McFadyen, I.; Moore, M. J.; Senn, J. J.; Stanton, M. G.; Almarsson, Ö.; Ciaramella, G. and Brito, L. A.(2019).Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines, Molecular therapy. Nucleic acids 15 : 1–11.

[2] Chen, Y. Y.; Syed, A. M.; MacMillan, P.; Rocheleau, J. V. and Chan, W. C. W.(2020). Flow Rate Affects Nanoparticle Uptake into Endothelial Cells, Advanced materials 32 : 1906274.

[3] Grifoni, A.; Weiskopf, D.; Ramirez, S. I.; Mateus, J.; Dan, J. M.; Moderbacher, C. R.; Rawlings, S. A.; Sutherland, A.; Premkumar, L.; Jadi, R. S. and et al.(2020). Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals, Cell 181 : 1489–1501.e15.

[4] Nelde, A.; Bilich, T.; Heitmann, J. S.; Maringer, Y.; Salih, H. R.; Roerden, M.; Lübke, M.; Bauer, J.; Rieth, J.; Wacker, M.; Peter, A.; Hörber, S.; Traenkle, B.; Kaiser, P. D.; Rothbauer, U.; Becker, M.; Junker, D.; Krause, G.; Strengert, M.; Schneiderhan-Marra, N.; Templin, M. F.; Joos, T. O.; Kowalewski, D. J.; Stos-Zweifel, V.; Fehr, M.; Rabsteyn, A.; Mirakaj, V.; Karbach, J.; Jäger, E.; Graf, M.; Gruber, L.-C.; Rachfalski, D.; Preuß, B.; Hagelstein, I.; Märklin, M.; Bakchoul, T.; Gouttefangeas, C.; Kohlbacher, O.; Klein, R.; Stevanović, S.; Rammensee, H.-G. and Walz, J. S.(2020). SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition, Nature immunology.

[5] Sekine, T.; Perez-Potti, A.; Rivera-Ballesteros, O.; Strålin, K.; Gorin, J.-B.; Olsson, A.; Llewellyn-Lacey, S.; Kamal, H.; Bogdanovic, G.; Muschiol, S. and et al.(2020). Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19, Cell 183 : 158–168.e14.

[6] Zhang, S.; Liu, Y.; Wang, X.; Yang, L.; Li, H.; Wang, Y.; Liu, M.; Zhao, X.; Xie, Y.; Yang, Y.; Zhang, S.; Fan, Z.; Dong, J.; Yuan, Z.; Ding, Z.; Zhang, Y. and Hu, L.(2020). SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19, Journal of hematology & oncology 13 : 120.

[7] Lippi, G.; Plebani, M. and Henry, B. M.(2020).Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis, Clin. Chim. Acta 506 : 145–148.

[8] Grady, D. (2021). A Few Covid Vaccine Recipients Developed a Rare Blood Disorder, The New York Times, Feb. 8, 2021.

Yours faithfully,

Professsor Sucharit Bhakdi MD, Professor Emeritus of Medical Microbiology and Immunology, Former Chair, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University of Mainz (Medical Doctor and Scientist) (Germany and Thailand)

Dr Marco Chiesa MD FRCPsych, Consultant Psychiatrist and Visiting Professor, University College London (Medical Doctor) (United Kingdom and Italy)

Dr C Stephen Frost BSc MBChB Specialist in Diagnostic Radiology, Stockholm, Sweden (Medical Doctor) (United Kingdom and Sweden)

Dr Margareta Griesz-Brisson MD PhD, Consultant Neurologist and Neurophysiologist (studied Medicine in Freiburg, Germany, speciality training for Neurology at New York University, Fellowship in Neurophysiology at Mount Sinai Medical Centre, New York City; PhD in Pharmacology with special interest in chronic low level neurotoxicology and effects of environmental factors on brain health), Medical Director, The London Neurology and Pain Clinic (Medical Doctor and Scientist) (Germany and United Kingdom)

Professor Martin Haditsch MD PhD, Specialist (Austria) in Hygiene and Microbiology, Specialist (Germany) in Microbiology, Virology, Epidemiology/Infectious Diseases, Specialist (Austria) in Infectious Diseases and Tropical Medicine, Medical Director, TravelMedCenter, Leonding, Austria, Medical Director, Labor Hannover MVZ GmbH (Medical Doctor and Scientist) (Austria and Germany)

Professor Stefan Hockertz, Professor of Toxicology and Pharmacologym, European registered Toxicologist, Specialist in Immunology and Immunotoxicology, CEO tpi consult GmbH. (Scientist) (Germany)

Dr Lissa Johnson, BSc BA(Media) MPsych(Clin) PhD, Clinical Psychologist and Behavioural Psychologist, Expertise in the social psychology of torture, atrocity, collective violence and fear propaganda, Former member Australian Psychological Society Public Interest Advisory Group (Clinical Psychologist and Behavioural Scientist) (Australia)

Professor Ulrike Kämmerer PhD, Associate Professor of Experimental Reproductive Immunology and Tumor Biology at the Department of Obstetrics and Gynaecology, University Hospital of Würzburg, Germany, Trained molecular virologist (Diploma, PhD-Thesis) and Immunologist (Habilitation), Remains engaged in active laboratory research (Molecular Biology, Cell Biology (Scientist) (Germany)

Associate Professor Michael Palmer MD, Department of Chemistry (studied Medicine and Medical Microbiology in Germany, has taught Biochemistry since 2001 in present university in Canada; focus on Pharmacology, metabolism, biological membranes, computer programming; experimental research focus on bacterial toxins and antibiotics (Daptomycin); has written a textbook on Biochemical Pharmacology, University of Waterloo, Ontario, Canada (Medical Doctor and Scientist) (Canada and Germany)

Professor Karina Reiss PhD, Professor of Biochemistry, Christian Albrecht University of Kiel, Expertise in Cell Biology, Biochemistry (Scientist) (Germany)

Professor Andreas Sönnichsen MD, Professor of General Practice and Family Medicine, Department of General Practice and Family Medicine, Center of Public Health, Medical University of Vienna, Vienna (Medical Doctor) (Austria)

Dr Michael Yeadon BSc (Joint Honours in Biochemistry and Toxicology) PhD (Pharmacology), Formerly Vice President & Chief Scientific Officer Allergy & Respiratory, Pfizer Global R&D; Co-founder & CEO, Ziarco Pharma Ltd.; Independent Consultant (Scientist) (United Kingdom)

֎֎֎

 

Statement on urgent open letter from doctors and scientists to EMA regarding Covid-19 vaccine safety concerns – Professor Sucharit Bhakdi

March 10, 2021

https://lbry.tv/@Doctors4CovidEthics:d/Prof.-Sucharit-Bhakdi-statement-on-EMA-open-letter.ENG:0

֎֎֎

 

Ärzte und Wissenschaftler schreiben an die Europäische Arzneimittelbehörde und warnen vor den Gefahren des Covid-19-Impfstoffs – OffGuardian

Ärzte und Wissenschaftler schreiben an die Europäische Arzneimittelbehörde und warnen vor den Gefahren des Covid-19-Impfstoffs – OffGuardian

15.3.2021

Eine Pressemitteilung der Kampagne „Doctors for Covid Ethics

Quelle: Doctors & Scientists Write to European Medicines Agency Warning of COVID-19 Vaccine Dangers – OffGuardian

Eine Gruppe von Wissenschaftlern und Ärzten hat heute einen offenen Brief veröffentlicht, in dem sie die Europäische Arzneimittelbehörde (EMA) auffordert, dringende Sicherheitsfragen zu den COVID-19-Impfstoffen zu beantworten oder die Zulassung des Impfstoffs zurückzuziehen.

Der Brief beschreibt schwerwiegende mögliche Folgen der COVID-19-Impfstofftechnologie und warnt vor möglichen Autoimmunreaktionen, Blutgerinnungsstörungen, Schlaganfall und inneren Blutungen, „auch im Gehirn, Rückenmark und Herz“.

Die Autoren fordern Belege dafür, dass jede skizzierte medizinische Gefahr „in präklinischen Tiermodellen mit allen drei Impfstoffen vor ihrer Zulassung für die Anwendung am Menschen durch die EMA ausgeschlossen wurde.“

„Sollten solche Beweise nicht vorliegen“, schreiben die Autoren, „fordern wir, dass die Zulassung für die Verwendung der genbasierten Impfstoffe zurückgezogen wird, bis alle oben genannten Fragen durch die Ausübung der Sorgfaltspflicht durch die EMA ordnungsgemäß geklärt sind.“

Der Brief ist an Emer Cooke, die Exekutivdirektorin der EMA, gerichtet und wurde am Montag, den 1. März 2021, abgeschickt. Der Brief wurde in Kopie an den Präsidenten des Europarates und den Präsidenten der Europäischen Kommission geschickt.

Darin heißt es:

„Wir unterstützen prinzipiell den Einsatz neuer medizinischer Interventionen.“ Allerdings „gibt es ernsthafte Bedenken, einschließlich, aber nicht beschränkt auf die oben genannten, dass die Zulassung der COVID-19-Impfstoffe durch die EMA voreilig und rücksichtslos war, und dass die Verabreichung der Impfstoffe einen ‚Menschenversuch‘ darstellte und darstellt, was ein Verstoß gegen den Nürnberger Kodex war und ist.“

Sie können den vollständigen Brief hier lesen und das Video-Statement von Professor Sucharit Bhakdi, emeritierter Professor für Medizinische Mikrobiologie und Immunologie und ehemaliger Vorsitzender des Instituts für Medizinische Mikrobiologie und Hygiene, hier ansehen.

In einer öffentlichen Erklärung sagte die Gruppe:

„Kaum hatten wir unseren Brief abgegeben, warnte die norwegische Arzneimittelbehörde, dass die COVID-19-Impfstoffe möglicherweise zu riskant für den Einsatz bei gebrechlichen älteren Menschen sind, genau der Gruppe, die diese Impfstoffe schützen sollen. Wir fügen hinzu, dass es aufgrund des Wirkmechanismus der Impfstoffe, die Produktion des Spike-Proteins anzuregen, das ungünstige pathophysiologische Eigenschaften hat, auch gefährdete Personen geben kann, die nicht alt und bereits krank sind.

Neue Daten zeigen, dass Impfstoff-Nebenwirkungen dreimal so häufig bei Personen auftreten, die sich zuvor z. B. mit dem Coronavirus infiziert haben. Keiner der Impfstoffe wurde bisher länger als ein paar Monate klinisch getestet, was für den Nachweis von Sicherheit und Wirksamkeit einfach zu kurz ist.

Deshalb halten wir es als Ausgangspunkt für wichtig, alle Todesfälle, die innerhalb von 28 Tagen nach der Impfung aufgetreten sind, aufzuzählen und zu bewerten und die Krankheitsbilder mit denen zu vergleichen, die nicht geimpft wurden.

In Bezug auf die Entwicklung von COVID-19-Impfstoffen hat die Parlamentarische Versammlung des Europarats in ihrer Resolution 2361 vom 27. Januar 2021 erklärt, dass die Mitgliedsstaaten sicherstellen müssen, dass alle COVID-19-Impfstoffe durch qualitativ hochwertige Studien unterstützt werden, die solide sind und auf ethische Weise durchgeführt werden.

Die EMA-Beamten und andere Zulassungsbehörden in den EU-Ländern sind an diese Kriterien gebunden. Sie sollten darauf aufmerksam gemacht werden, dass sie möglicherweise gegen die Resolution 2361 verstoßen, wenn sie Medizinprodukte anwenden, die sich noch in Phase-3-Studien befinden.

Gemäß Resolution 2361 müssen die Mitgliedsstaaten die Bürger auch darüber informieren, dass die Impfung NICHT verpflichtend ist und sicherstellen, dass niemand politisch, sozial oder anderweitig unter Druck gesetzt wird, sich impfen zu lassen. Die Staaten müssen außerdem sicherstellen, dass niemand diskriminiert wird, weil er den Impfstoff nicht erhält.“

Der Brief kommt zu einem Zeitpunkt, an dem eine Petition gegen die Pläne der britischen Regierung für Impfpässe 270.000 Unterschriften erreicht hat, mehr als das Doppelte der Zahl, die erforderlich ist, um die Abgeordneten zur Debatte zu zwingen. Die Petition wird am 15. März 2021 im britischen Parlament debattiert werden.

Für Kommentare wenden Sie sich bitte an Professor Sucharit Bhakdi oder Assistenzprofessor Michael Palmer.

Ärzte und Wissenschaftler können den offenen Brief unterschreiben, indem sie ihren Namen, ihre Qualifikation, ihre Fachgebiete und das Land, in dem sie praktizieren, an folgende Adresse schicken: Doctors4CovidEthics@protonmail.com.

֎֎֎

———- Forwarded message ———
Von: Doctors for Covid Ethics <Doctors4CovidEthics@protonmail.com>
Date: Fr., 2. Apr. 2021 um 14:29 Uhr
Subject: Update – reply from EMA to Doctors for Covid Ethics, and our rebuttal
 
Dear colleagues and fellow signatories,
 
Thank you for your valuable support for our open letter to to the European Medicines Agency (EMA) regarding COVID-19 vaccine dangers. By way of update, on March 23rd we received a reply from the EMA. In their reply, the EMA dismissed our concerns as relating to rare and minor events, asserting a positive risk-benefit balance for all vaccines.
 
Yesterday, April 1st, we issued a rebuttal letter, which we made public, along with the EMA’s letter to us. The correspondence is summarised in the press release below, with links to all letters involved. We hope you find this update useful. 
 
More signatories are being processed at present, and will be listed online shortly. We have created a category for signatories in allied disciplines relating to ethics and human rights, so please don’t hesitate to invite your colleagues and friends in the law or other relevant fields to email us to add their signature if they would like.
 
Thank you once again for lending your credibility and integrity to this endeavour.
 
With our best regards and respect,
Doctors for Covid Ethics
 
 

PRESS RELEASE – FOR IMMEDIATE RELEASE

Doctors and Scientists Accuse Medical Regulator of Downplaying COVID-19 Vaccine Dangers

The European Medicines Agency is misleading citizens into medical experimentation, experts warn

April 1st 2021

Doctors and scientists from 25 countries have today issued a rebuttal letter to the European Medicines Agency (EMA), following the regulator’s dismissal of their earlier warnings regarding COVID-19 vaccine dangers from clotting and bleeding.

Within days of the EMA receiving the group’s original letter on March 1st, outlining risks of blood disorders from COVID-19 vaccines, over a dozen countries suspended the AstraZeneca vaccine following deaths from clotting and bleeding, as the doctors had warned. 

On March 23rd, however, the EMA dismissed the group’s concerns as relating to “minor” and “rare” events, concluding that “a positive benefit-risk balance has been established.”

The doctors and scientists have today hit back, accusing the EMA of misleading the public on the vaccines’ true risk-benefit profile. “Your reply of March 23 is unconvincing and unacceptable,” they wrote, noting that recorded cases of life-threatening cerebral venous thrombosis (CSVT) post-vaccination likely “represent just the tip of a huge iceberg”. Common reactions to vaccination, including headache, nausea, blurred vision and vomiting, they state, are symptoms of CSVT, and should be assessed as such, immediately.

Clotting and bleeding after vaccination can also “be expected to increase with each re-vaccination, and each intervening coronavirus exposure” the group warned. Over time “this renders both repeated vaccination and common coronaviruses dangerous to young and healthy age groups, for whom – in the absence of ‘vaccination’ – COVID-19 poses no substantive risk.

“Such is the real risk-benefit analysis of the COVID-19 ‘vaccines’. Either the EMA lacks the subject-matter expertise to appreciate the molecular science of this reality, or it lacks the medical ethics to act accordingly.”

The group, Doctors for Covid Ethics, which includes professors of immunology and microbiology, described the EMA’s responses to their concerns as “unscientific”, “vague”, and lacking credibility. The experts have offered to liaise with the agency to mitigate against vaccination risks and ethics violations, including helping the EMA to “craft a focussed pharmacovigilance plan.” 

The group warned that continuing to administer inadequately tested gene-based COVID-19 vaccines represents dangerous medical experimentation, whose “true risks far outweigh any theoretical benefits”, reflecting “serious violations of medical ethics and citizens’ medical rights.”

“Misleading populations into accepting investigational agents such as the gene-based COVID-19 ‘vaccines’, or coercing them through ‘vaccine passports’, constitutes clear and egregious violations of the Nuremberg Code”, they caution. 

The letter is addressed to Emer Cooke, Executive Director of the EMA, and was copied to the lawyer Reiner Fuellmich, Charles Michel, President of the Council of Europe, and Ursula von der Leyen, President of the European Commission.  

 
 

For comment contact Professor Sucharit Bhakdi MD: sucharit.bhakdi@gmx.de, or Associate Professor Michael Palmer MD:mpalmer@uwaterloo.ca

Doctors for Covid Ethics is a group of over 100 doctors and scientists from 25 countries 

Web: https://doctors4covidethics.medium.com

Twitter: https://twitter.com/Drs4CovidEthics

 

Further resources

Original Doctors for Covid Ethics letter to EMA (Delivered March 1st):  https://doctors4covidethics.medium.com/urgent-open-letter-from-doctors-and-scientists-to-the-european-medicines-agency-regarding-covid-19-f6e17c311595

Video statement (March 11th) by Professor Sucharit Bhakdi, Professor Emeritus of Medical Microbiology and Immunology and Former Chair, Institute of Medical Microbiology and Hygiene: https://lbry.tv/@Doctors4CovidEthics:d/Prof.-Sucharit-Bhakdi-statement-on-EMA-open-letter.ENG:0

Doctors, scientists, lawyers and colleagues in allied disciplines can sign the open letters by sending their name, qualifications, areas of expertise and country of practice to:Doctors4CovidEthics@protonmail.com, with web verification (eg workplace or registration link, not for publication).